drugset / Trial / NCT01937416

Autologous Bone Marrow Mononuclear Cells Therapy in Diabetic Lower Limb Ischemia

NCT01937416

Phase 1 Unknown 10 enrolled Hebei Medical University
NaSingle-groupOpen-labelTreatment

Summary

This study is to evaluate the safety and efficacy of autologous bone marrow mononuclear cells transplantation in diabetic patients with lower limb ischemia.

Timeline

Start
2012-01
Primary completion
2013-09
Completion
2014-12

Drugs

EvaluationDrugModalityDoseRoute
Subject autologous bone marrow mononuclear cells Cell therapy Intramuscular